<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524758</url>
  </required_header>
  <id_info>
    <org_study_id>oculusgen 2006-02-20</org_study_id>
    <nct_id>NCT00524758</nct_id>
  </id_info>
  <brief_title>Oculusgen (Ologen) Glaucoma MMC Control in Estonia</brief_title>
  <official_title>Comprative Study of the Safety and Effectiveness Between Oculusgen (Ologen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pro Top &amp; Mediking Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pro Top &amp; Mediking Company Limited</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and effectiveness between ologen collagen matrix and mitomycin-C (MMC)
      in glaucoma surgery.

      The ologen collagen matrix implantation procedure is same as traditional trabeculectomy
      except implant the ologen collagen matrix on the top of sclera flap after one loose stich the
      sclera flap. The MMC application is as the standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ologen collagen matrix is implanted on the top of sclera flap after the loose stich sclera
      flap is done for the filtering surgery. The concept of ologen collagen matrix is to creat the
      subconjunctiva bleb and modulate the wound healing for the surgery. By implanting ologen
      collagen matrix in the place, subconjuctival and trabdoor scars might be prevented. This is
      because the ologen collagen matrix is a 3-D scaffold porous structure that can guide
      fibroblast to grow randomly, instead of linear alignment. This can reduce the scar formation.

      Doctors apply MMC for the glaucoma surgery is also trying to inhibite the scar formation. But
      MMC has been long time used and glaucoma specialists have not found anything to replace it.

      Ologen collagen matrix concept is not INHIBITION, it is guiding and creating a physiological
      tissue. The successful of ologen collagen matrix may be on par with MMC but the safety and
      side effects will be much less.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IOP &lt;21mmHg without anti glaucoma medication</measure>
    <time_frame>180 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IOP&lt;21mmHg or IOP drops more than 30% with anti glaucoma medication</measure>
    <time_frame>180-day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <condition>Angle Closure Glaucoma</condition>
  <condition>Uveitis Glaucoma</condition>
  <condition>Young Age Glaucoma</condition>
  <condition>Neovascular Glaucoma</condition>
  <condition>High Risk Patient</condition>
  <arm_group>
    <arm_group_label>Ologen in Trabeculectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ologen in Trabeculectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MMC in Trabeculectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>MMC in Trabeculectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ologen (oculusgen) collagen matrix</intervention_name>
    <description>Implant ologen collagen matrix on the top of sclera flap after loose stiched the sclera flap. The traditional trabeculectomy is performed.</description>
    <arm_group_label>Ologen in Trabeculectomy</arm_group_label>
    <other_name>ologen collagen matrix</other_name>
    <other_name>oculusgen collagen matrix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MMC in Trabeculectomy</intervention_name>
    <description>MMC in Trabeculectomy</description>
    <arm_group_label>MMC in Trabeculectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Max anti glaucoma medication failed,

        Exclusion Criteria:

          -  Age less than 18, woman in pregnant, hemodialysis patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuldar Kaljurand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tartu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tartu University Clinics</name>
      <address>
        <city>Tartu</city>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2007</study_first_submitted>
  <study_first_submitted_qc>September 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2007</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ologen</keyword>
  <keyword>oculusgen</keyword>
  <keyword>collagen matrix</keyword>
  <keyword>trabeculectomy</keyword>
  <keyword>filtering surgery</keyword>
  <keyword>mitomycin-C</keyword>
  <keyword>MMC</keyword>
  <keyword>Aeon Astron</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Glaucoma, Angle-Closure</mesh_term>
    <mesh_term>Glaucoma, Neovascular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

